Joel D Allen

44PUBLICATIONS
312CO-AUTHORS
NanomaterialsManufacturing safety and qualityGene and molecular therapyInnate immunityIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Aug 13, 2026
Author Correction: Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

|Jun 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144.

|Jun 08, 2026
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.

|May 07, 2026
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.

|Mar 04, 2026
Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Tugba Atabey, Ronald Derking, Maddy L Newby

|Feb 13, 2026
Rapidly acquired HIV-1 neutralization breadth in a rhesus V2 apex knockin mouse model after a single bolus immunization.

Amrit Raj Ghosh, Rumi Habib, Nitesh Mishra

Pageof 8

Frequent Collaborators

43 joint publications

Max Crispin

24 joint publications

Andrew B Ward

10 joint publications

Christopher A Cottrell

10 joint publications

Ian A Wilson